Telix Pharmaceuticals Ltd Sustainability Reports

Telix Pharmaceuticals Limited is a biopharmaceutical company that focuses on the development and commercialization of molecularly targeted radiation products for cancer management.

Sector: Health Care

Country: Australia

Exchange: Australian Securities Exchange

ISIN: AU000000TLX2

10 reports from 2017 to 2025

Company Profile

Telix Pharmaceuticals Ltd

Telix Pharmaceuticals Limited is a biopharmaceutical company that focuses on the development and commercialization of molecularly targeted radiation products for cancer management.

MIC

 

Ticker

 

ISIN

 

Website

www.telixpharma.com

Reports

Available reports